These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 17115426

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A strand-loop-strand structure is a possible intermediate in fibril elongation: long time simulations of amyloid-beta peptide (10-35).
    Han W, Wu YD.
    J Am Chem Soc; 2005 Nov 09; 127(44):15408-16. PubMed ID: 16262404
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Density functional theory analysis and spectral studies on amyloid peptide Abeta(28-35) and its mutants A30G and A30I.
    Nagarajan S, Rajadas J, Malar EJ.
    J Struct Biol; 2010 Jun 09; 170(3):439-50. PubMed ID: 20188180
    [Abstract] [Full Text] [Related]

  • 8. An intersheet packing interaction in A beta fibrils mapped by disulfide cross-linking.
    Shivaprasad S, Wetzel R.
    Biochemistry; 2004 Dec 14; 43(49):15310-7. PubMed ID: 15581343
    [Abstract] [Full Text] [Related]

  • 9. FTIR spectroscopic studies on aggregation process of the beta-amyloid 11-28 fragment and its variants.
    Juszczyk P, Kołodziejczyk AS, Grzonka Z.
    J Pept Sci; 2009 Jan 14; 15(1):23-9. PubMed ID: 19023881
    [Abstract] [Full Text] [Related]

  • 10. A molecular dynamics approach to the structural characterization of amyloid aggregation.
    Cecchini M, Curcio R, Pappalardo M, Melki R, Caflisch A.
    J Mol Biol; 2006 Apr 07; 357(4):1306-21. PubMed ID: 16483608
    [Abstract] [Full Text] [Related]

  • 11. Alzheimer's Abeta peptides containing an isostructural backbone mutation afford distinct aggregate morphologies but analogous cytotoxicity. Evidence for a common low-abundance toxic structure(s)?
    Bieschke J, Siegel SJ, Fu Y, Kelly JW.
    Biochemistry; 2008 Jan 08; 47(1):50-9. PubMed ID: 18078350
    [Abstract] [Full Text] [Related]

  • 12. Mechanism of copper(II) inhibiting Alzheimer's amyloid beta-peptide from aggregation: a molecular dynamics investigation.
    Jiao Y, Yang P.
    J Phys Chem B; 2007 Jul 05; 111(26):7646-55. PubMed ID: 17564430
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Lipid-induced conformational transition of the amyloid core fragment Abeta(28-35) and its A30G and A30I mutants.
    Nagarajan S, Ramalingam K, Neelakanta Reddy P, Cereghetti DM, Padma Malar EJ, Rajadas J.
    FEBS J; 2008 May 05; 275(10):2415-27. PubMed ID: 18422968
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Synthesis, aggregation, neurotoxicity, and secondary structure of various A beta 1-42 mutants of familial Alzheimer's disease at positions 21-23.
    Murakami K, Irie K, Morimoto A, Ohigashi H, Shindo M, Nagao M, Shimizu T, Shirasawa T.
    Biochem Biophys Res Commun; 2002 May 31; 294(1):5-10. PubMed ID: 12054732
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.